Lilly, Boehringer to co-market Cymbalta

Boehringer Ingelheim (Ingelheim, Germany) received rights to co-market LLY's Cymbalta duloxetine to treat stress urinary incontinence (SUI) worldwide, except in Japan. LLY will receive up to $280 mill...